{"id":7436,"date":"2024-09-16T07:11:07","date_gmt":"2024-09-16T14:11:07","guid":{"rendered":"https:\/\/highfieldbio.com\/?p=7436"},"modified":"2024-12-18T06:19:45","modified_gmt":"2024-12-18T14:19:45","slug":"data-from-a-phase-1-trial-of-highfield-biopharmaceuticals-hf1k16-show-the-new-immuno-oncology-drug-is-safe-and-signals-efficacy-in-treating-refractory-metastatic-cancers","status":"publish","type":"post","link":"https:\/\/highfieldbio.com\/zh\/2024\/09\/16\/data-from-a-phase-1-trial-of-highfield-biopharmaceuticals-hf1k16-show-the-new-immuno-oncology-drug-is-safe-and-signals-efficacy-in-treating-refractory-metastatic-cancers\/","title":{"rendered":"HighField Biopharmaceuticals \u7684 HF1K16 \u4e00\u671f\u4e34\u5e8a\u8bd5\u9a8c\u6570\u636e\u663e\u793a\uff0c\u8fd9\u79cd\u65b0\u578b\u514d\u75ab\u80bf\u7624\u836f\u7269\u662f\u5b89\u5168\u7684\uff0c\u4e14\u5728\u6cbb\u7597\u96be\u6cbb\u6027\u8f6c\u79fb\u6027\u764c\u75c7\u65b9\u9762\u6709\u6548"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"7436\" class=\"elementor elementor-7436\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-7c3df96 elementor-section-boxed elementor-section-height-default elementor-section-height-default smart-sticky-default\" data-id=\"7c3df96\" data-element_type=\"section\">\r\n\t\t\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\r\n\t\t\t\t\r\n\t\t\t\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-f09d554\" data-id=\"f09d554\" data-element_type=\"column\">\r\n\r\n\t\t\t\t\r\n\t\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\r\n\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-33706a9 elementor-widget elementor-widget-spacer\" data-id=\"33706a9\" data-element_type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-7f9ed22 elementor-widget elementor-widget-udesign_widget_heading\" data-id=\"7f9ed22\" data-element_type=\"widget\" data-widget_type=\"udesign_widget_heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"title-wrapper  title-cross title-center\"><p class=\"title elementor-heading-title\">2024 \u5e74 9 \u6708 16 \u65e5 | HighField Bio \u65b0\u95fb\u7a3f<\/p><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b2ac3db elementor-widget elementor-widget-spacer\" data-id=\"b2ac3db\" data-element_type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ac618a2 elementor-widget elementor-widget-udesign_widget_heading\" data-id=\"ac618a2\" data-element_type=\"widget\" data-widget_type=\"udesign_widget_heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"title-wrapper  title-center\"><h2 class=\"title elementor-heading-title\">HighField Biopharmaceuticals \u7684 HF1K16 \u4e00\u671f\u4e34\u5e8a\u8bd5\u9a8c\u6570\u636e\u663e\u793a\uff0c\u8fd9\u79cd\u65b0\u578b\u514d\u75ab\u80bf\u7624\u836f\u7269\u662f\u5b89\u5168\u7684\uff0c\u4e14\u5728\u6cbb\u7597\u96be\u6cbb\u6027\u8f6c\u79fb\u6027\u764c\u75c7\u65b9\u9762\u6709\u6548<\/h2><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\r\n\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t<\/section>\r\n\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-027104d alpha-section-stretched elementor-section-boxed elementor-section-height-default elementor-section-height-default smart-sticky-default\" data-id=\"027104d\" data-element_type=\"section\">\r\n\t\t\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\r\n\t\t\t\t\r\n\t\t\t\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-a846582\" data-id=\"a846582\" data-element_type=\"column\">\r\n\r\n\t\t\t\t\r\n\t\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\r\n\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-ed689c6 elementor-widget elementor-widget-text-editor\" data-id=\"ed689c6\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p class=\"bwalignc\" style=\"text-align: center;\"><strong><i>\u6b63\u5728\u8fdb\u884c\u7684\u7b2c 1 \u9636\u6bb5\u7814\u7a76\u7684\u6570\u636e\u4e8e 2024 \u5e74 9 \u6708 14 \u65e5\u5728\u897f\u73ed\u7259\u5df4\u585e\u7f57\u90a3\u4e3e\u884c\u7684\u6b27\u6d32\u80bf\u7624\u5185\u79d1\u5b66\u4f1a\u5927\u4f1a\u7684\u6d77\u62a5\u5c55\u793a\u4e2d\u8fdb\u884c\u4e86\u5c55\u793a\u3002<\/i><\/strong><\/p><p class=\"bwalignc\" style=\"text-align: center;\"><strong><i>HF1K16\uff08K16\uff09\u9776\u5411\u9ad3\u7cfb\u6291\u5236\u7ec6\u80de\uff08MDSC\uff09\uff0cR\/R \u80f6\u8d28\u7624\u961f\u5217\u8868\u660e\uff0c\u8be5\u836f\u7269\u5177\u6709\u751f\u5b58\u76ca\u5904\uff0c\u6570\u540d\u60a3\u8005\u5b58\u6d3b\u65f6\u95f4\u8d85\u8fc7 2 \u5e74<\/i><\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-e59da4e elementor-widget-laptop__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"e59da4e\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>\u4e2d\u56fd\u676d\u5dde\u20132024 \u5e74 9 \u6708 16 \u65e5\u2013<a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fhighfieldbio.com%2F&amp;esheet=54122116&amp;newsitemid=20240916674303&amp;lan=en-US&amp;anchor=HighField+Biopharmaceuticals&amp;index=1&amp;md5=0c382f3a9a4a666e85d448eb04ff3ba8\" target=\"_blank\" rel=\"nofollow noopener\" shape=\"rect\">\u6d77\u83f2\u5c14\u5fb7\u751f\u7269\u5236\u836f<\/a>\u662f\u4e00\u5bb6\u4f7f\u7528\u8102\u8d28\u7597\u6cd5\u6cbb\u7597\u764c\u75c7\u3001\u7cd6\u5c3f\u75c5\u548c\u5176\u4ed6\u75be\u75c5\u7684\u4e34\u5e8a\u9636\u6bb5\u516c\u53f8\uff0c\u4eca\u5929\u5ba3\u5e03\u5176\u9996\u5e2d\u6267\u884c\u5b98\u517c\u79d1\u5b66\u521b\u59cb\u4eba\u5f90\u5b87\u7ea2\u535a\u58eb\u5728 HF1K16\uff08K16\uff09\u6cbb\u7597\u96be\u6cbb\u6027\u8f6c\u79fb\u6027\u764c\u75c7\u60a3\u8005\u6b63\u5728\u8fdb\u884c\u7684 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\uff0c\u53d6\u5f97\u4e86\u79ef\u6781\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u7ed3\u679c\u3002\u00a0<a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.esmo.org%2Fmeeting-calendar%2Fesmo-congress-2024%2F&amp;esheet=54122116&amp;newsitemid=20240916674303&amp;lan=en-US&amp;anchor=European+Society+of+Medical+Oncology+%28ESMO%29+Congress&amp;index=2&amp;md5=926b118e2a28f94292c2bd90560ede8e\" target=\"_blank\" rel=\"nofollow noopener\" shape=\"rect\">\u6b27\u6d32\u80bf\u7624\u5185\u79d1\u5b66\u4f1a\uff08ESMO\uff09\u5927\u4f1a<\/a>\u00a02024 \u5e74 9 \u6708 13 \u65e5\u81f3 17 \u65e5\uff0c\u897f\u73ed\u7259\u5df4\u585e\u7f57\u90a3\u3002<\/p><div class=\"bw-release-story\"><p>K16 \u662f\u4e00\u79cd\u5305\u8986 ATRA \u7684\u514d\u75ab\u8c03\u8282\u8102\u8d28\u4f53\uff0c\u7ed3\u5408\u4e86\u8102\u8d28\u53cc\u5c42\u7ed3\u6784\u548c\u5168\u53cd\u5f0f\u7ef4\u7532\u9178 (ATRA)\u3002\u5b83\u9488\u5bf9\u672a\u6210\u719f\u7684\u514d\u75ab\u7ec6\u80de\uff0c\u5373\u9ad3\u7cfb\u6291\u5236\u7ec6\u80de (MDSC)\uff0c\u8bf1\u5bfc\u5b83\u4eec\u6210\u4e3a\u6210\u719f\u7684\u6d3b\u6027\u514d\u75ab\u7ec6\u80de\uff0c\u4f8b\u5982\u6811\u7a81\u72b6\u7ec6\u80de\uff0c\u4ece\u800c\u53ec\u5524 T \u7ec6\u80de\u653b\u51fb\u764c\u75c7\u3002<\/p><p>\u5c55\u793a\u9898\u4e3a\u201c<a href=\"https:\/\/highfieldbio.com\/wp-content\/uploads\/2024\/09\/HighFieldBio_Esmo2024.jpg\" target=\"_blank\" rel=\"nofollow noopener\" shape=\"rect\">\u9ad3\u7cfb\u6291\u5236\u7ec6\u80de\u8c03\u8282\u5242 HF1K16 \u5728\u96be\u6cbb\u6027\u548c\u8f6c\u79fb\u6027\u764c\u75c7\u60a3\u8005\u4e2d\u7684 1 \u671f\u7814\u7a76\uff1a\u521d\u6b65\u7597\u6548\u548c\u5b89\u5168\u6027<\/a>\u201d\uff0c\u4e8e 9 \u6708 14 \u65e5\u661f\u671f\u516d\u5728\u7814\u7a76\u6027\u514d\u75ab\u6cbb\u7597\u4f1a\u8bae\u4e0a\u53d1\u8868\u3002<\/p><p>\u5f90\u535a\u58eb\u8868\u793a\uff1a\u201c\u6211\u4eec\u5bf9\u6b63\u5728\u8fdb\u884c\u7684 1 \u671f\u7814\u7a76\u7684\u521d\u6b65\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u6570\u636e\u611f\u5230\u5174\u594b\u3002ATRA \u662f\u4e00\u79cd\u5728\u4f53\u5185\u5e38\u89c1\u7684\u9ad8\u6d3b\u6027\u7ef4\u751f\u7d20 A \u4ee3\u8c22\u7269\u3002\u5229\u7528 Highfield \u7684\u8102\u8d28\u4f53\u6280\u672f\uff0c\u6211\u4eec\u80fd\u591f\u6ce8\u5c04\u9ad8\u6d53\u5ea6\u7684 ATRA\uff0c\u4e3a\u60a3\u8005\u63d0\u4f9b\u6bd4\u6b63\u5e38\u66b4\u9732\u91cf\u9ad8 10 \u500d\u4ee5\u4e0a\u7684\u5242\u91cf\uff0c\u4ece\u800c\u89e6\u53d1\u6cbb\u7597\u673a\u5236\u3002\u8fd9\u4e9b\u60a3\u8005\u7684\u80bf\u7624\u975e\u5e38\u665a\u671f\uff0c\u4e4b\u524d\u63a5\u53d7\u8fc7\u5927\u91cf\u6cbb\u7597\u3002\u201d<\/p><p>\u7b2c 1 \u9636\u6bb5\u5242\u91cf\u9012\u589e\u7814\u7a76\uff08<a href=\"https:\/\/clinicaltrials.gov\/search?intr=NCT05388487\" target=\"_blank\" rel=\"nofollow noopener\" shape=\"rect\">NCT05388487<\/a>) \u663e\u793a\u51fa\u7406\u60f3\u7684\u514d\u75ab\u8c03\u8282\u548c\u7597\u6548\u7684\u663e\u8457\u4fe1\u53f7\u3002\u76ee\u524d\u6b63\u5728\u62db\u52df\u7684\u6269\u5c55\u961f\u5217\u4e13\u6ce8\u4e8e R\/R \u80f6\u8d28\u7624\u3002\u622a\u81f3 2024 \u5e74 9 \u6708 1 \u65e5\uff0c\u5df2\u6709 19 \u540d\u60a3\u6709 II\u3001III \u548c IV \u7ea7\u80bf\u7624\u7684\u60a3\u8005\u5165\u7ec4\u3002\u5728 10 \u540d\u60a3\u6709 II \u7ea7\u548c III \u7ea7\u80f6\u8d28\u7624\u7684\u60a3\u8005\u4e2d\uff0c\u4e2d\u4f4d\u603b\u751f\u5b58\u671f (mOS) \u4e3a 629 \u5929\u3002\u5bf9\u4e8e 9 \u540d\u60a3\u6709 IV \u7ea7\u6216\u80f6\u8d28\u6bcd\u7ec6\u80de\u7624\uff08\u6700\u5177\u4fb5\u88ad\u6027\u7684\u8111\u80bf\u7624\uff09\u7684\u60a3\u8005\uff0cmOS \u4e3a 315 \u5929\u3002<\/p><p>\u4e0b\u4e00\u6b65\u5c06\u5728\u7b2c\u4e8c\u9636\u6bb5\u7814\u7a76\u4e2d\u786e\u5b9a\u4f5c\u4e3a\u5355\u4e00\u836f\u7269\u6216\u4e0e\u5176\u4ed6\u6807\u51c6\u6cbb\u7597\u65b9\u6848\u8054\u5408\u4f7f\u7528\u6700\u6709\u76ca\u7684\u9002\u5e94\u75c7\u3002<\/p><p><b>\u5173\u4e8e HighField \u751f\u7269\u5236\u836f<\/b><\/p><p>Highfield \u662f\u4e00\u5bb6\u4e34\u5e8a\u9636\u6bb5\u516c\u53f8\uff0c\u4e13\u6ce8\u4e8e\u9488\u5bf9\u514d\u75ab\u80bf\u7624\u5b66\u548c\u5176\u4ed6\u75be\u75c5\u7684\u57fa\u56e0\u6cbb\u7597\u7684\u8102\u8d28\u4f53\u7ed3\u6784\u7684\u65b0\u5e94\u7528\u3002\u8be5\u516c\u53f8\u8fd8\u62e5\u6709\u4e00\u4e2a\u7814\u53d1\u4e2d\u5fc3\u548c\u4e00\u4e2a\u7b26\u5408 GMP \u7684\u751f\u4ea7\u8bbe\u65bd\u3002HighField \u7684\u4e3b\u8981\u4e34\u5e8a\u5f00\u53d1\u9879\u76ee\u662f HFK16\uff0c\u4e00\u79cd\u836f\u7269\u5305\u5c01\u7684\u514d\u75ab\u8c03\u8282\u8102\u8d28\u4f53\u3002\u8be5\u516c\u53f8\u7684\u4ea7\u54c1\u7ebf\u8fd8\u5305\u62ec LipoADCplex<sup>\u5546\u6807\u00a0<\/sup>\u5e73\u53f0\u5305\u62ec\u7528\u4e8e\u5b9e\u4f53\u80bf\u7624\u7684\u836f\u7269\u5305\u5c01\u514d\u75ab\u8102\u8d28\u4f53\u4ee5\u53ca\u7528\u4e8e\u57fa\u56e0\u4f20\u9012\u548c\u57fa\u56e0\u6cbb\u7597\u7684 LNP \u7597\u6cd5\u3002\u66f4\u591a\u4fe1\u606f\u8bf7\u8bbf\u95ee\u00a0<a href=\"https:\/\/highfieldbio.com\/zh\/\">https:\/\/highfieldbio.com<\/a><\/p><\/div><div class=\"bw-release-contact\"><h2>\u8054\u7cfb\u65b9\u5f0f<\/h2><p>\u5a92\u4f53\u8054\u7cfb\u65b9\u5f0f\uff1a<br \/>\u4e39\u00b7\u57c3\u62c9\u7c73\u5b89<br \/>Opus \u751f\u7269\u6280\u672f\u901a\u8baf<br \/><a href=\"mailto:danieleramian@comcast.net\" target=\"_blank\" rel=\"nofollow noopener\" shape=\"rect\">danieleramian@comcast.net<\/a><br \/>425-306-8716<\/p><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\r\n\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t<\/section>\r\n\t\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>HighField Biopharmaceuticals \u7684 HF1K16 \u7684 1 \u671f\u8bd5\u9a8c\u6570\u636e\u663e\u793a\uff0c\u8fd9\u79cd\u65b0\u578b\u514d\u75ab\u80bf\u7624\u836f\u7269\u662f\u5b89\u5168\u7684\uff0c\u5e76\u8868\u660e\u5176\u5728\u6cbb\u7597\u96be\u6cbb\u6027\u8f6c\u79fb\u6027\u764c\u75c7\u65b9\u9762\u6709\u6548\u3002\u6b63\u5728\u8fdb\u884c\u7684 1 \u671f\u7814\u7a76\u7684\u6570\u636e\u4e8e 2024 \u5e74 9 \u6708 14 \u65e5\u5728\u897f\u73ed\u7259\u5df4\u585e\u7f57\u90a3\u4e3e\u884c\u7684\u6b27\u6d32\u533b\u5b66\u80bf\u7624\u5b66\u4f1a\u5927\u4f1a\u4e0a\u4ee5\u6d77\u62a5\u5f62\u5f0f\u5c55\u793a\u3002HF1K16 (K16) [\u2026]<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[22],"tags":[],"class_list":["post-7436","post","type-post","status-publish","format-standard","hentry","category-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Data from a Phase 1 Trial of HighField Biopharmaceuticals\u2019 HF1K16 Show the New Immuno-Oncology Drug is Safe and Signals Efficacy in Treating Refractory Metastatic Cancers - HighField Biopharmaceuticals<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/highfieldbio.com\/zh\/2024\/09\/16\/data-from-a-phase-1-trial-of-highfield-biopharmaceuticals-hf1k16-show-the-new-immuno-oncology-drug-is-safe-and-signals-efficacy-in-treating-refractory-metastatic-cancers\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Data from a Phase 1 Trial of HighField Biopharmaceuticals\u2019 HF1K16 Show the New Immuno-Oncology Drug is Safe and Signals Efficacy in Treating Refractory Metastatic Cancers - HighField Biopharmaceuticals\" \/>\n<meta property=\"og:description\" content=\"Data from a Phase 1 Trial of HighField Biopharmaceuticals\u2019 HF1K16 Show the New Immuno-Oncology Drug is Safe and Signals Efficacy in Treating Refractory Metastatic Cancers The data from the ongoing Phase 1 study was featured in a poster presentation September 14, 2024, at the European Society of Medical Oncology Congress in Barcelona, Spain. HF1K16 (K16) [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/highfieldbio.com\/zh\/2024\/09\/16\/data-from-a-phase-1-trial-of-highfield-biopharmaceuticals-hf1k16-show-the-new-immuno-oncology-drug-is-safe-and-signals-efficacy-in-treating-refractory-metastatic-cancers\/\" \/>\n<meta property=\"og:site_name\" content=\"HighField Biopharmaceuticals\" \/>\n<meta property=\"article:published_time\" content=\"2024-09-16T14:11:07+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-18T14:19:45+00:00\" \/>\n<meta name=\"author\" content=\"PJWCreative\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/highfieldbio.com\/2024\/09\/16\/data-from-a-phase-1-trial-of-highfield-biopharmaceuticals-hf1k16-show-the-new-immuno-oncology-drug-is-safe-and-signals-efficacy-in-treating-refractory-metastatic-cancers\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/highfieldbio.com\/2024\/09\/16\/data-from-a-phase-1-trial-of-highfield-biopharmaceuticals-hf1k16-show-the-new-immuno-oncology-drug-is-safe-and-signals-efficacy-in-treating-refractory-metastatic-cancers\/\"},\"author\":{\"name\":\"PJWCreative\",\"@id\":\"https:\/\/highfieldbio.com\/#\/schema\/person\/7ec00570bf3fa5a022cd1b08bda3b0f0\"},\"headline\":\"Data from a Phase 1 Trial of HighField Biopharmaceuticals\u2019 HF1K16 Show the New Immuno-Oncology Drug is Safe and Signals Efficacy in Treating Refractory Metastatic Cancers\",\"datePublished\":\"2024-09-16T14:11:07+00:00\",\"dateModified\":\"2024-12-18T14:19:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/highfieldbio.com\/2024\/09\/16\/data-from-a-phase-1-trial-of-highfield-biopharmaceuticals-hf1k16-show-the-new-immuno-oncology-drug-is-safe-and-signals-efficacy-in-treating-refractory-metastatic-cancers\/\"},\"wordCount\":516,\"publisher\":{\"@id\":\"https:\/\/highfieldbio.com\/#organization\"},\"articleSection\":[\"Press Release\"],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/highfieldbio.com\/2024\/09\/16\/data-from-a-phase-1-trial-of-highfield-biopharmaceuticals-hf1k16-show-the-new-immuno-oncology-drug-is-safe-and-signals-efficacy-in-treating-refractory-metastatic-cancers\/\",\"url\":\"https:\/\/highfieldbio.com\/2024\/09\/16\/data-from-a-phase-1-trial-of-highfield-biopharmaceuticals-hf1k16-show-the-new-immuno-oncology-drug-is-safe-and-signals-efficacy-in-treating-refractory-metastatic-cancers\/\",\"name\":\"Data from a Phase 1 Trial of HighField Biopharmaceuticals\u2019 HF1K16 Show the New Immuno-Oncology Drug is Safe and Signals Efficacy in Treating Refractory Metastatic Cancers - HighField Biopharmaceuticals\",\"isPartOf\":{\"@id\":\"https:\/\/highfieldbio.com\/#website\"},\"datePublished\":\"2024-09-16T14:11:07+00:00\",\"dateModified\":\"2024-12-18T14:19:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/highfieldbio.com\/2024\/09\/16\/data-from-a-phase-1-trial-of-highfield-biopharmaceuticals-hf1k16-show-the-new-immuno-oncology-drug-is-safe-and-signals-efficacy-in-treating-refractory-metastatic-cancers\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/highfieldbio.com\/2024\/09\/16\/data-from-a-phase-1-trial-of-highfield-biopharmaceuticals-hf1k16-show-the-new-immuno-oncology-drug-is-safe-and-signals-efficacy-in-treating-refractory-metastatic-cancers\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/highfieldbio.com\/2024\/09\/16\/data-from-a-phase-1-trial-of-highfield-biopharmaceuticals-hf1k16-show-the-new-immuno-oncology-drug-is-safe-and-signals-efficacy-in-treating-refractory-metastatic-cancers\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/highfieldbio.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Data from a Phase 1 Trial of HighField Biopharmaceuticals\u2019 HF1K16 Show the New Immuno-Oncology Drug is Safe and Signals Efficacy in Treating Refractory Metastatic Cancers\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/highfieldbio.com\/#website\",\"url\":\"https:\/\/highfieldbio.com\/\",\"name\":\"HighField Bio\",\"description\":\"Lipid-based Therapeutics Targeting the Tumor Microenvironment\",\"publisher\":{\"@id\":\"https:\/\/highfieldbio.com\/#organization\"},\"alternateName\":\"HighField Biopharmaceuticals\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/highfieldbio.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/highfieldbio.com\/#organization\",\"name\":\"HighField Biopharmaceuticals, Inc.\",\"alternateName\":\"HighField Bio\",\"url\":\"https:\/\/highfieldbio.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/highfieldbio.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/highfieldbio.com\/wp-content\/uploads\/2021\/07\/HIGHfield_logo_horizontal_FINAL_trans.png\",\"contentUrl\":\"https:\/\/highfieldbio.com\/wp-content\/uploads\/2021\/07\/HIGHfield_logo_horizontal_FINAL_trans.png\",\"width\":1500,\"height\":494,\"caption\":\"HighField Biopharmaceuticals, Inc.\"},\"image\":{\"@id\":\"https:\/\/highfieldbio.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/highfield-biopharma\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/highfieldbio.com\/#\/schema\/person\/7ec00570bf3fa5a022cd1b08bda3b0f0\",\"name\":\"PJWCreative\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/highfieldbio.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7558191085f3c167c2c5972a9ba86696e53fc4dec7eeb7b3e0cc15866c48b55f?s=80&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7558191085f3c167c2c5972a9ba86696e53fc4dec7eeb7b3e0cc15866c48b55f?s=80&d=mm&r=g\",\"caption\":\"PJWCreative\"},\"sameAs\":[\"https:\/\/highfieldbio.com\"],\"url\":\"https:\/\/highfieldbio.com\/zh\/author\/pjwcreative\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"HighField Biopharmaceuticals \u7684 HF1K16 \u7b2c\u4e00\u9636\u6bb5\u8bd5\u9a8c\u6570\u636e\u663e\u793a\uff0c\u8fd9\u79cd\u65b0\u578b\u514d\u75ab\u80bf\u7624\u836f\u7269\u662f\u5b89\u5168\u7684\uff0c\u5e76\u663e\u793a\u51fa\u5728\u6cbb\u7597\u96be\u6cbb\u6027\u8f6c\u79fb\u6027\u764c\u75c7\u65b9\u9762\u7684\u7597\u6548 - HighField Biopharmaceuticals","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/highfieldbio.com\/zh\/2024\/09\/16\/data-from-a-phase-1-trial-of-highfield-biopharmaceuticals-hf1k16-show-the-new-immuno-oncology-drug-is-safe-and-signals-efficacy-in-treating-refractory-metastatic-cancers\/","og_locale":"zh_CN","og_type":"article","og_title":"Data from a Phase 1 Trial of HighField Biopharmaceuticals\u2019 HF1K16 Show the New Immuno-Oncology Drug is Safe and Signals Efficacy in Treating Refractory Metastatic Cancers - HighField Biopharmaceuticals","og_description":"Data from a Phase 1 Trial of HighField Biopharmaceuticals\u2019 HF1K16 Show the New Immuno-Oncology Drug is Safe and Signals Efficacy in Treating Refractory Metastatic Cancers The data from the ongoing Phase 1 study was featured in a poster presentation September 14, 2024, at the European Society of Medical Oncology Congress in Barcelona, Spain. HF1K16 (K16) [&hellip;]","og_url":"https:\/\/highfieldbio.com\/zh\/2024\/09\/16\/data-from-a-phase-1-trial-of-highfield-biopharmaceuticals-hf1k16-show-the-new-immuno-oncology-drug-is-safe-and-signals-efficacy-in-treating-refractory-metastatic-cancers\/","og_site_name":"HighField Biopharmaceuticals","article_published_time":"2024-09-16T14:11:07+00:00","article_modified_time":"2024-12-18T14:19:45+00:00","author":"PJWCreative","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/highfieldbio.com\/2024\/09\/16\/data-from-a-phase-1-trial-of-highfield-biopharmaceuticals-hf1k16-show-the-new-immuno-oncology-drug-is-safe-and-signals-efficacy-in-treating-refractory-metastatic-cancers\/#article","isPartOf":{"@id":"https:\/\/highfieldbio.com\/2024\/09\/16\/data-from-a-phase-1-trial-of-highfield-biopharmaceuticals-hf1k16-show-the-new-immuno-oncology-drug-is-safe-and-signals-efficacy-in-treating-refractory-metastatic-cancers\/"},"author":{"name":"PJWCreative","@id":"https:\/\/highfieldbio.com\/#\/schema\/person\/7ec00570bf3fa5a022cd1b08bda3b0f0"},"headline":"Data from a Phase 1 Trial of HighField Biopharmaceuticals\u2019 HF1K16 Show the New Immuno-Oncology Drug is Safe and Signals Efficacy in Treating Refractory Metastatic Cancers","datePublished":"2024-09-16T14:11:07+00:00","dateModified":"2024-12-18T14:19:45+00:00","mainEntityOfPage":{"@id":"https:\/\/highfieldbio.com\/2024\/09\/16\/data-from-a-phase-1-trial-of-highfield-biopharmaceuticals-hf1k16-show-the-new-immuno-oncology-drug-is-safe-and-signals-efficacy-in-treating-refractory-metastatic-cancers\/"},"wordCount":516,"publisher":{"@id":"https:\/\/highfieldbio.com\/#organization"},"articleSection":["Press Release"],"inLanguage":"zh-Hans"},{"@type":"WebPage","@id":"https:\/\/highfieldbio.com\/2024\/09\/16\/data-from-a-phase-1-trial-of-highfield-biopharmaceuticals-hf1k16-show-the-new-immuno-oncology-drug-is-safe-and-signals-efficacy-in-treating-refractory-metastatic-cancers\/","url":"https:\/\/highfieldbio.com\/2024\/09\/16\/data-from-a-phase-1-trial-of-highfield-biopharmaceuticals-hf1k16-show-the-new-immuno-oncology-drug-is-safe-and-signals-efficacy-in-treating-refractory-metastatic-cancers\/","name":"HighField Biopharmaceuticals \u7684 HF1K16 \u7b2c\u4e00\u9636\u6bb5\u8bd5\u9a8c\u6570\u636e\u663e\u793a\uff0c\u8fd9\u79cd\u65b0\u578b\u514d\u75ab\u80bf\u7624\u836f\u7269\u662f\u5b89\u5168\u7684\uff0c\u5e76\u663e\u793a\u51fa\u5728\u6cbb\u7597\u96be\u6cbb\u6027\u8f6c\u79fb\u6027\u764c\u75c7\u65b9\u9762\u7684\u7597\u6548 - HighField Biopharmaceuticals","isPartOf":{"@id":"https:\/\/highfieldbio.com\/#website"},"datePublished":"2024-09-16T14:11:07+00:00","dateModified":"2024-12-18T14:19:45+00:00","breadcrumb":{"@id":"https:\/\/highfieldbio.com\/2024\/09\/16\/data-from-a-phase-1-trial-of-highfield-biopharmaceuticals-hf1k16-show-the-new-immuno-oncology-drug-is-safe-and-signals-efficacy-in-treating-refractory-metastatic-cancers\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/highfieldbio.com\/2024\/09\/16\/data-from-a-phase-1-trial-of-highfield-biopharmaceuticals-hf1k16-show-the-new-immuno-oncology-drug-is-safe-and-signals-efficacy-in-treating-refractory-metastatic-cancers\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/highfieldbio.com\/2024\/09\/16\/data-from-a-phase-1-trial-of-highfield-biopharmaceuticals-hf1k16-show-the-new-immuno-oncology-drug-is-safe-and-signals-efficacy-in-treating-refractory-metastatic-cancers\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/highfieldbio.com\/"},{"@type":"ListItem","position":2,"name":"Data from a Phase 1 Trial of HighField Biopharmaceuticals\u2019 HF1K16 Show the New Immuno-Oncology Drug is Safe and Signals Efficacy in Treating Refractory Metastatic Cancers"}]},{"@type":"WebSite","@id":"https:\/\/highfieldbio.com\/#website","url":"https:\/\/highfieldbio.com\/","name":"\u9ad8\u7530\u751f\u7269","description":"\u9488\u5bf9\u80bf\u7624\u5fae\u73af\u5883\u7684\u8102\u8d28\u7597\u6cd5","publisher":{"@id":"https:\/\/highfieldbio.com\/#organization"},"alternateName":"HighField Biopharmaceuticals","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/highfieldbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Organization","@id":"https:\/\/highfieldbio.com\/#organization","name":"\u6d77\u83f2\u5c14\u5fb7\u751f\u7269\u5236\u836f\u6709\u9650\u516c\u53f8","alternateName":"HighField Bio","url":"https:\/\/highfieldbio.com\/","logo":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/highfieldbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/highfieldbio.com\/wp-content\/uploads\/2021\/07\/HIGHfield_logo_horizontal_FINAL_trans.png","contentUrl":"https:\/\/highfieldbio.com\/wp-content\/uploads\/2021\/07\/HIGHfield_logo_horizontal_FINAL_trans.png","width":1500,"height":494,"caption":"HighField Biopharmaceuticals, Inc."},"image":{"@id":"https:\/\/highfieldbio.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/highfield-biopharma"]},{"@type":"Person","@id":"https:\/\/highfieldbio.com\/#\/schema\/person\/7ec00570bf3fa5a022cd1b08bda3b0f0","name":"PJW\u521b\u610f","image":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/highfieldbio.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/7558191085f3c167c2c5972a9ba86696e53fc4dec7eeb7b3e0cc15866c48b55f?s=80&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7558191085f3c167c2c5972a9ba86696e53fc4dec7eeb7b3e0cc15866c48b55f?s=80&d=mm&r=g","caption":"PJWCreative"},"sameAs":["https:\/\/highfieldbio.com"],"url":"https:\/\/highfieldbio.com\/zh\/author\/pjwcreative\/"}]}},"_links":{"self":[{"href":"https:\/\/highfieldbio.com\/zh\/wp-json\/wp\/v2\/posts\/7436","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/highfieldbio.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/highfieldbio.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/highfieldbio.com\/zh\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/highfieldbio.com\/zh\/wp-json\/wp\/v2\/comments?post=7436"}],"version-history":[{"count":10,"href":"https:\/\/highfieldbio.com\/zh\/wp-json\/wp\/v2\/posts\/7436\/revisions"}],"predecessor-version":[{"id":7530,"href":"https:\/\/highfieldbio.com\/zh\/wp-json\/wp\/v2\/posts\/7436\/revisions\/7530"}],"wp:attachment":[{"href":"https:\/\/highfieldbio.com\/zh\/wp-json\/wp\/v2\/media?parent=7436"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/highfieldbio.com\/zh\/wp-json\/wp\/v2\/categories?post=7436"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/highfieldbio.com\/zh\/wp-json\/wp\/v2\/tags?post=7436"}],"curies":[{"name":"\u53ef\u6e7f\u6027\u7c89\u5242","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}